BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6182844)

  • 1. Treatment of esophageal carcinoma combined preoperative chemotherapy.
    Bains MS; Kelsen DP; Beattie EJ; Martini N
    Ann Thorac Surg; 1982 Nov; 34(5):521-8. PubMed ID: 6182844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination chemotherapy of esophageal carcinoma using cisplatin, vindesine, and bleomycin.
    Kelsen DP; Bains M; Hilaris B; Chapman R; McCormack P; Alexander J; Hopfan S; Martini N
    Cancer; 1982 Mar; 49(6):1174-7. PubMed ID: 6174199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin, vindesine, and bleomycin chemotherapy of local-regional and advanced esophageal carcinoma.
    Kelsen D; Hilaris B; Coonley C; Chapman R; Lesser M; Dukeman M; Heelan R; Bains M
    Am J Med; 1983 Oct; 75(4):645-52. PubMed ID: 6194685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin, vindesine, and bleomycin (DVB) combination chemotherapy for esophageal carcinoma.
    Kelsen DP; Bains M; Chapman R; Golbey R
    Cancer Treat Rep; 1981; 65(9-10):781-5. PubMed ID: 6168370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus.
    Roth JA; Pass HI; Flanagan MM; Graeber GM; Rosenberg JC; Steinberg S
    J Thorac Cardiovasc Surg; 1988 Aug; 96(2):242-8. PubMed ID: 2456424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in chemotherapy of esophageal cancer.
    Kelsen DP
    Clin Bull; 1981; 11(3):131-8. PubMed ID: 6175446
    [No Abstract]   [Full Text] [Related]  

  • 7. Cisplatin, vindesine, and mitoguazone in the treatment of esophageal cancer.
    Kelsen DP; Fein R; Coonley C; Heelan R; Bains M
    Cancer Treat Rep; 1986 Feb; 70(2):255-9. PubMed ID: 3948190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and pathological evaluation of response to chemotherapy in patients with esophageal carcinoma.
    Kelsen DP; Heelan R; Coonley C; Bains M; Martini N; Hilaris B; Golbey RB
    Am J Clin Oncol; 1983 Oct; 6(5):539-46. PubMed ID: 6193704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preliminary results of a chemotherapy study of patients with squamous cell carcinoma in the head and neck region. Comparison of 2 therapeutic regimens: cis-diamminodichloroplatinum (II) and bleomycin compared to methotrexate and vindesine].
    von Heyden HW; Beyer JH; Matthaei A; Nagel GA; Schröder M
    Onkologie; 1981 Dec; 4(6):296-9. PubMed ID: 6175933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of epidermoid head and neck cancer with cisplatinum/bleomycin vs methotrexate/vindesine].
    Schröder M; von Heyden HW; Beyer JH; Klee M
    Laryngol Rhinol Otol (Stuttg); 1981 Jun; 60(6):331-3. PubMed ID: 6167831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy and radiation therapy before transhiatal esophagectomy for esophageal carcinoma.
    Orringer MB; Forastiere AA; Perez-Tamayo C; Urba S; Takasugi BJ; Bromberg J
    Ann Thorac Surg; 1990 Mar; 49(3):348-54; discussion 354-5. PubMed ID: 2106845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II evaluation of cisplatin, bleomycin, and vindesine in advanced squamous cell carcinoma of the esophagus: a Southeastern Cancer Study Group Trial.
    Dinwoodie WR; Bartolucci AA; Lyman GH; Velez-Garcia E; Martelo OJ; Sarma PR
    Cancer Treat Rep; 1986 Feb; 70(2):267-70. PubMed ID: 2418969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin, vindesine and bleomycin (CVB) combination chemotherapy of advanced non-small cell lung cancer.
    Itri LM; Gralla RJ; Kelsen DP; Chapman RA; Casper ES; Braun DW; Howard JE; Golbey R; Heelan RT
    Cancer; 1983 Mar; 51(6):1050-5. PubMed ID: 6185210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized trial comparing vindesine plus cisplatin with vinblastine plus cisplatin in patients with non-small cell lung cancer, with an analysis of methods of response assessment.
    Kris MG; Gralla RJ; Kalman LA; Kelsen DP; Casper ES; Burke MT; Groshen S; Cibas IR; Bagin R; Heelan RT
    Cancer Treat Rep; 1985 Apr; 69(4):387-95. PubMed ID: 3888388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vinblastine, bleomycin and cisplatin for recurrent or metastatic squamous cell carcinoma of the head and neck.
    Perry DJ; Weltz MD; Brown AW; Henderson RL; Neglia WJ; Berenberg JL
    Cancer; 1982 Dec; 50(11):2257-60. PubMed ID: 6182971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative therapy for esophageal cancer: a randomized comparison of chemotherapy versus radiation therapy.
    Kelsen DP; Minsky B; Smith M; Beitler J; Niedzwiecki D; Chapman D; Bains M; Burt M; Heelan R; Hilaris B
    J Clin Oncol; 1990 Aug; 8(8):1352-61. PubMed ID: 1696309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin, vinblastine, and mitoguazone chemotherapy for epidermoid and adenocarcinoma of the esophagus.
    Forastiere AA; Gennis M; Orringer MB; Agha FP
    J Clin Oncol; 1987 Aug; 5(8):1143-9. PubMed ID: 3625244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative mitomycin, ifosfamide, and cisplatin followed by esophagectomy in squamous cell carcinoma of the esophagus: pathologic complete response induced by chemotherapy leads to long-term survival.
    Darnton SJ; Archer VR; Stocken DD; Mulholland PJ; Casson AG; Ferry DR
    J Clin Oncol; 2003 Nov; 21(21):4009-15. PubMed ID: 14581424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined modality therapy of esophageal carcinoma.
    Kelsen DP; Ahuja R; Hopfan S; Bains MS; Kosloff C; Martini N; McCormack P; Golbey RB
    Cancer; 1981 Jul; 48(1):31-7. PubMed ID: 6165456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of neoadjuvant cisplatin, 5-fluorouracil and interferon-alpha in operable squamous cell carcinoma of the esophagus.
    Bazarbashi S; Abdelsalam M; Amin T; El-Bassiouni M; Soudy H; Elweshi A; Alhusseiny H; Rehman K; Memon M; Ajarim D
    Chemotherapy; 2008; 54(4):315-22. PubMed ID: 18701820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.